Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
9 /100
LOW RISK
Score updated Oct 13, 2026

VRTX — Vertex Pharmaceuticals Incorporated Dilution Risk Tracker

Track VRTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VRTX — Get alerts when the score changes →

As of October 13, 2026, Vertex Pharmaceuticals Incorporated (VRTX) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. Vertex Pharmaceuticals Incorporated has a market capitalization of $128.50B, 253.46M shares outstanding, 1698 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway—
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for VRTX.
🔔 Track VRTX — Get forecast alerts →

Market Data

Market Cap$128.50B
Shares Outstanding253.46M
Float253.02M
Cash$7.85B
Debt$105.00M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore9/100DilutionWatch score record
Shares Outstanding253.46MVerified float table or market cache
Public Float253.02MVerified float table or market cache
Market Cap$128.50BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 20.0% shares (2026Q1 vs prior)
1698 institutional holders · 294.36M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 33.03M shares
#2 Capital World Investors 25.37M shares
#3 BlackRock, Inc. 23.97M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.50M
Days to Cover4.2
% of Float1.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2016-02-16
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VRTX Dilution Snapshot

Vertex Pharmaceuticals Incorporated (VRTX) has a DilutionScore of 9/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VRTX's DilutionScore has held steady at 9/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 20269/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VRTX shares outstanding have decreased 0.1% from 254.00M (Mar 2026) to 253.81M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 08, 2026253.81M253.02M▼ 0.16%
May 07, 2026253.81M253.41M▲ 0.07%
Mar 13, 2026254.00M253.24M▼ 0.02%
Mar 09, 2026254.00M253.28M▲ 0.02%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VRTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VRTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VRTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VRTX
VRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.